233
Aldeyra Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
181
FY23:
148
FY24:
104
FY25:
71.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.38
FY22:
0.27
FY23:
0.52
FY24:
0.53
FY25:
0.28
Total assets
Change from FY21 to FY25
millions USD
FY21:
233
FY22:
181
FY23:
148
FY24:
105
FY25:
72.1
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
11.8
FY22:
15.4
FY23:
22.3
FY24:
18.6
FY25:
27.8
(negative)
Change from FY21 to FY25
millions USD
FY21:
15.6
FY22:
14.9
FY23:
6.27
FY24:
15.0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
206
FY22:
151
FY23:
120
FY24:
71.0
FY25:
44.3
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
233
FY22:
181
FY23:
148
FY24:
105
FY25:
72.1
All amounts in millions USD